Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Endo Branches Out With $370M Indevus Acquisition

Jan 05 2009

• By Randall Osborne

Related Content

Safety Fears Dog Indevus’ Testosterone Drug

Jul 02 2008

Endo Financials Strong, But Shareholder Calls For Sale Of Company

Feb 28 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window